INS and diabetes mellitus: Further, unlike canonical insulin signaling, ERK is not subject to downregulation in obesity, i.e. “insulin resistance” does not appear to limit further activation of ERK in hyperinsulinemia, diabetes, and obesity (Figure 1C and [64], [65]).